State Street’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,572,264
| Closed | -$45M | – | 3781 |
|
|
2018
Q4 | $45M | Sell |
1,572,264
-187,497
| -11% | -$5.33M | ﹤0.01% | 1419 |
|
|
2018
Q3 | $49.1M | Buy |
1,759,761
+230,612
| +15% | +$6.49M | ﹤0.01% | 1546 |
|
|
2018
Q2 | $42.7M | Buy |
1,529,149
+99,885
| +7% | +$2.68M | ﹤0.01% | 1587 |
|
|
2018
Q1 | $35.5M | Buy |
1,429,264
+17,785
| +1% | +$433K | ﹤0.01% | 1652 |
|
|
2017
Q4 | $34.2M | Buy |
1,411,479
+77,750
| +6% | +$2.05M | ﹤0.01% | 1696 |
|
|
2017
Q3 | $36.8M | Sell |
1,333,729
-7,081
| -0.5% | -$189K | ﹤0.01% | 1582 |
|
|
2017
Q2 | $33.6M | Buy |
1,340,810
+104,007
| +8% | +$2.58M | ﹤0.01% | 1621 |
|
|
2017
Q1 | $33.2M | Buy |
1,236,803
+28,103
| +2% | +$776K | ﹤0.01% | 1580 |
|
|
2016
Q4 | $31.7M | Buy |
1,208,700
+26,359
| +2% | +$652K | ﹤0.01% | 1563 |
|
|
2016
Q3 | $29.5M | Buy |
1,182,341
+138,613
| +13% | +$3.23M | ﹤0.01% | 1510 |
|
|
2016
Q2 | $22.6M | Sell |
1,043,728
-131,524
| -11% | -$2.35M | ﹤0.01% | 1670 |
|
|
2016
Q1 | $17.6M | Buy |
1,175,252
+130,075
| +12% | +$2.18M | ﹤0.01% | 1813 |
|
|
2015
Q4 | $22.9M | Sell |
1,045,177
-100,104
| -9% | -$1.87M | ﹤0.01% | 1615 |
|
|
2015
Q3 | $18.1M | Sell |
1,145,281
-73,081
| -6% | -$1.17M | ﹤0.01% | 1816 |
|
|
2015
Q2 | $17.4M | Buy |
1,218,362
+167,377
| +16% | +$2.83M | ﹤0.01% | 1945 |
|
|
2015
Q1 | $18.2M | Buy |
1,050,985
+45,159
| +4% | +$798K | ﹤0.01% | 1907 |
|
|
2014
Q4 | $18M | Buy |
1,005,826
+8,922
| +0.9% | +$144K | ﹤0.01% | 1878 |
|
|
2014
Q3 | $13.1M | Sell |
996,904
-14,001
| -1% | -$189K | ﹤0.01% | 2023 |
|
|
2014
Q2 | $14.5M | Sell |
1,010,905
-25,248
| -2% | -$330K | ﹤0.01% | 2020 |
|
|
2014
Q1 | $13.2M | Buy |
1,036,153
+33,128
| +3% | +$432K | ﹤0.01% | 2046 |
|
|
2013
Q4 | $10M | Buy |
1,003,025
+14,858
| +2% | +$169K | ﹤0.01% | 2195 |
|
|
2013
Q3 | $13M | Buy |
988,167
+63,695
| +7% | +$836K | ﹤0.01% | 1980 |
|
|
2013
Q2 | $13.2M | Buy |
+924,472
| New | +$11.6M | ﹤0.01% | 1891 |
|
Other funds holding NXTM
State Street's NXTM Position: Q1 2019 in Review
State Street sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,572,264 shares — an estimated $45M sold.
State Street first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $49.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- State Street reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- State Street sold 1,572,264 NxStage Medical Inc. shares in Q1 2019, an estimated $45M.
- State Street first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- State Street's NxStage Medical Inc. position peaked at $49.1M in Q3 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on State Street's 13F filing for Q1 2019, filed 15 May 2019.